Fresh blow to UK life sciences as MSD abandons £1bn project
MSD is scrapping a £1 billion ($1.35 billion) expansion of its UK operations – including a facility already under construction in London – saying the country does not value innovative medicines. The decision to abandon work on the R&D facility in King’s Cross and lay off 125 scientists and administrative staff is another body blow…
